Cargando…
Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide
Treatment of thrombocytopenia in systemic lupus erythematosus (SLE) is considered in cases of current bleeding, severe bruising, or a platelet count below 50,000/µL. Corticosteroid is the first choice of medication for inducing remission, and immunosuppressive agents can be added when thrombocytopen...
Autores principales: | Park, Hee-Jin, Kang, Mi-il, Kang, Yoon, Chung, Soo-jin, Lee, Sang-Won, Park, Yong-Beom, Lee, Soo-Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594614/ https://www.ncbi.nlm.nih.gov/pubmed/23487584 http://dx.doi.org/10.3346/jkms.2013.28.3.472 |
Ejemplares similares
-
Splenectomy for refractory thrombocytopenia in juvenile systemic lupus erythematosus
por: Campos, LMA, et al.
Publicado: (2008) -
Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012) -
Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus
por: Shima, Natsuki, et al.
Publicado: (2018) -
Water Intoxication Following Low-Dose Intravenous Cyclophosphamide
por: Koo, Tai Yeon, et al.
Publicado: (2007) -
Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus
por: Binello, Nicolò, et al.
Publicado: (2018)